The 2017 Top 10 Global Orthopedic Device Firms

The 2023 version is ready and live online. Click here to review the latest Top Companies list!

This year’s Top 10 company report illuminated a number of trends within the orthopedic market. Companies are, ironically, finding the largest growth areas to be the smallest bones in the body and are pursuing ways to gain admission into the promising extremities market. For example, Wright Medical—which divested its large joint business in 2015—last year sold the large joint portfolio it had acquired from Tornier to become a dedicated extremities and biologics company. “Our large joints business has excellent products and significant market share in key European markets with a loyal customer base,” Wright president and CEO Robert Palmisano said after divesting the business. “However, this business is not in line with our strategy to be the premier extremities and biologics company.”

The larger OEMs were less enthusiastic about establishing themselves in extremities. Rather, they are seeking to further diversify their portfolios and expand their presence by acquiring peripheral technologies to their mainstay businesses. Stryker Corp., for example, added emergency medicine technology, RF generators, and disposable products to their offering. Zimmer Biomet, on the other hand, augmented its portfolio with diagnostics and 3D imaging systems. Others reinforced their core businesses through M&A as well. Smith & Nephew strengthened its sports medicine business by acquiring a biologic tissue repair product, and NuVasive continued its commitment to minimally invasive procedures by purchasing a magnetic spinal rod system that can be adjusted non-invasively. Finally, Globus Medical enhanced its global presence through the acquisition of Alphatec’s international spinal product distribution network.

We hope you enjoy reading this year’s Top 10 report.

Editors’ note: As you read our report, please take note that while the companies are ranked according to sales reported for FY 2016 (though we do provide some 2017 figures to date where possible), some may include non-device sales within a division, such as combination products, drug delivery, software, or device-related services. Not all companies explicitly break out the device portion of total revenues. We consulted numerous public documents and contacted company officials as needed to arrive at the best estimates.

Contributors
Editor: Sean Fenske • Managing Editor: Michael Barbella • Associate Editor: Sam Brusco

TOP ORTHOPEDIC DEVICE FIRMS

1. Stryker	$11.3B
2. DePuy Synthes	$9.3B
3. Zimmer Biomet	$7.7B
4. Smith & Nephew	$4.7B
5. Medtronic Spine	$2.9B
6. DJO Global	$1.2B
7. Integra LifeSciences	$992M
8. NuVasive	$962M
9. Wright Medical	$690M
10. Globus Medical	$564M